The Medicines Company buys Annovation Biopharma

The Medicines Company said Wednesday it acquired all the outstanding equity of Annovation Biopharma, a portfolio company of Atlas Venture. Financial terms weren’t announced. Cambridge, Massachusetts-based Annovation aims to create safer therapies for anesthesia and critical care.

4 February 2015•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail